Adverse events to antiretrovirals in the Swiss HIV Cohort Study : effect on mortality and treatment modification
- Author
- KEISER, Olivia1 ; FELLAY, Jacques2 ; OPRAVIL, Milos3 ; HIRSCH, Hans H4 ; HIRSCHEL, Bernard5 ; BERNASCONI, Enos6 ; VERNAZZA, Pietro L7 ; RICKENBACH, Martin8 ; TELENTI, Amalio2 ; FURRER, Hansjakob9
[1] Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland
[2] Division of Infectious Diseases and Institute of Microbiology, University Hospital Lausanne, CHUV, Switzerland
[3] Division of Infectious Diseases, University Hospital Zürich, Switzerland
[4] Infectious Diseases and Hospital Epidemiolgy, University Hospital and Institute for Medical Microbiology, University of Basel, Switzerland
[5] Division of Infectious Diseases, University Hospital Geneva, Switzerland
[6] Division of Infectious Diseases, Ospedale Regionale di Lugano, Switzerland
[7] Division of Infectious Diseases, Kantonsspital St. Gallen, Switzerland
[8] Data Centre of the Swiss HIV Cohort Study, Lausanne, Switzerland
[9] Division of Infectious Diseases, University Hospital Bern, University of Bern, Switzerland
Swiss HIV Cohort Study, Switzerland - Source
Antiviral therapy (London). 2007, Vol 12, Num 8, pp 1157-1164, 8 p ; ref : 29 ref
- ISSN
- 1359-6535
- Scientific domain
- Microbiology, infectious diseases; Pharmacology drugs; Virology
- Publisher
- International Medical Press, London
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antirétroviral Antiviral Effet secondaire Etude cohorte Homme Mortalité SIDA Santé publique Toxicité Traitement Virus immunodéficience humaine Immunodéficit Immunopathologie Infection Lentivirus Retroviridae Virose Virus
- Keyword (en)
- Antiretroviral agent Antiviral Secondary effect Cohort study Human Mortality AIDS Public health Toxicity Treatment Human immunodeficiency virus Immune deficiency Immunopathology Infection Lentivirus Retroviridae Viral disease Virus
- Keyword (es)
- Antiretroviral Antiviral Efecto secundario Estudio cohorte Hombre Mortalidad SIDA Salud pública Toxicidad Tratamiento Human immunodeficiency virus Inmunodeficiencia Inmunopatología Infección Lentivirus Retroviridae Virosis Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S05 Antiviral agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02D Viral diseases of the lymphoid tissue and the blood. Aids
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B06 Immunopathology / 002B06D Immunodeficiencies. Immunoglobulinopathies / 002B06D01 Immunodeficiencies
- Discipline
- Immunopathology Infectious pathology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 19995343
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1177/135965350701200808 
https://dx.doi.org/10.1177/135965350701200808
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1177\/135965350701200808\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"Adverse events to antiretrovirals in the Swiss HIV Cohort Study : effect on mortality and treatment modification\";s:9:\"\u0000*\u0000jtitle\";s:26:\"Antiviral therapy (London)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Antivir. ther. (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"12\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:4:\"1157\";s:8:\"\u0000*\u0000epage\";s:4:\"1164\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1359-6535\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"KEISER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Olivia\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"FELLAY, Jacques\";i:1;s:14:\"OPRAVIL, Milos\";i:2;s:14:\"HIRSCH, Hans H\";i:3;s:17:\"HIRSCHEL, Bernard\";i:4;s:16:\"BERNASCONI, Enos\";i:5;s:18:\"VERNAZZA, Pietro L\";i:6;s:18:\"RICKENBACH, Martin\";i:7;s:15:\"TELENTI, Amalio\";i:8;s:17:\"FURRER, Hansjakob\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"Adverse events to antiretrovirals in the Swiss HIV Cohort Study : effect on mortality and treatment modification\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:27:\"International Medical Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1177\/135965350701200808\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"Adverse events to antiretrovirals in the Swiss HIV Cohort Study : effect on mortality and treatment modification\";s:9:\"\u0000*\u0000jtitle\";s:26:\"Antiviral therapy (London)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Antivir. ther. (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"12\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:4:\"1157\";s:8:\"\u0000*\u0000epage\";s:4:\"1164\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1359-6535\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"KEISER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Olivia\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"FELLAY, Jacques\";i:1;s:14:\"OPRAVIL, Milos\";i:2;s:14:\"HIRSCH, Hans H\";i:3;s:17:\"HIRSCHEL, Bernard\";i:4;s:16:\"BERNASCONI, Enos\";i:5;s:18:\"VERNAZZA, Pietro L\";i:6;s:18:\"RICKENBACH, Martin\";i:7;s:15:\"TELENTI, Amalio\";i:8;s:17:\"FURRER, Hansjakob\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"Adverse events to antiretrovirals in the Swiss HIV Cohort Study : effect on mortality and treatment modification\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:27:\"International Medical Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.1177\/135965350701200808\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1177\/135965350701200808\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"Adverse events to antiretrovirals in the Swiss HIV Cohort Study : effect on mortality and treatment modification\";s:9:\"\u0000*\u0000jtitle\";s:26:\"Antiviral therapy (London)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Antivir. ther. (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"12\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:4:\"1157\";s:8:\"\u0000*\u0000epage\";s:4:\"1164\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1359-6535\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"KEISER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Olivia\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"FELLAY, Jacques\";i:1;s:14:\"OPRAVIL, Milos\";i:2;s:14:\"HIRSCH, Hans H\";i:3;s:17:\"HIRSCHEL, Bernard\";i:4;s:16:\"BERNASCONI, Enos\";i:5;s:18:\"VERNAZZA, Pietro L\";i:6;s:18:\"RICKENBACH, Martin\";i:7;s:15:\"TELENTI, Amalio\";i:8;s:17:\"FURRER, Hansjakob\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"Adverse events to antiretrovirals in the Swiss HIV Cohort Study : effect on mortality and treatment modification\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:27:\"International Medical Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1177\/135965350701200808\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"Adverse events to antiretrovirals in the Swiss HIV Cohort Study : effect on mortality and treatment modification\";s:9:\"\u0000*\u0000jtitle\";s:26:\"Antiviral therapy (London)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Antivir. ther. (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"12\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:4:\"1157\";s:8:\"\u0000*\u0000epage\";s:4:\"1164\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1359-6535\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"KEISER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Olivia\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"FELLAY, Jacques\";i:1;s:14:\"OPRAVIL, Milos\";i:2;s:14:\"HIRSCH, Hans H\";i:3;s:17:\"HIRSCHEL, Bernard\";i:4;s:16:\"BERNASCONI, Enos\";i:5;s:18:\"VERNAZZA, Pietro L\";i:6;s:18:\"RICKENBACH, Martin\";i:7;s:15:\"TELENTI, Amalio\";i:8;s:17:\"FURRER, Hansjakob\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"Adverse events to antiretrovirals in the Swiss HIV Cohort Study : effect on mortality and treatment modification\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:27:\"International Medical Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1177\/135965350701200808\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"Adverse events to antiretrovirals in the Swiss HIV Cohort Study : effect on mortality and treatment modification\";s:9:\"\u0000*\u0000jtitle\";s:26:\"Antiviral therapy (London)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Antivir. ther. (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"12\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:4:\"1157\";s:8:\"\u0000*\u0000epage\";s:4:\"1164\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1359-6535\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"KEISER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Olivia\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"FELLAY, Jacques\";i:1;s:14:\"OPRAVIL, Milos\";i:2;s:14:\"HIRSCH, Hans H\";i:3;s:17:\"HIRSCHEL, Bernard\";i:4;s:16:\"BERNASCONI, Enos\";i:5;s:18:\"VERNAZZA, Pietro L\";i:6;s:18:\"RICKENBACH, Martin\";i:7;s:15:\"TELENTI, Amalio\";i:8;s:17:\"FURRER, Hansjakob\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"Adverse events to antiretrovirals in the Swiss HIV Cohort Study : effect on mortality and treatment modification\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:27:\"International Medical Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
